Colasanti, T.; Stefanantoni, K.; Fantini, C.; Corinaldesi, C.; Vasile, M.; Marampon, F.; Di Luigi, L.; Antinozzi, C.; Sgrò, P.; Lenzi, A.;
et al. The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis. Int. J. Mol. Sci. 2022, 23, 10150.
https://doi.org/10.3390/ijms231710150
AMA Style
Colasanti T, Stefanantoni K, Fantini C, Corinaldesi C, Vasile M, Marampon F, Di Luigi L, Antinozzi C, Sgrò P, Lenzi A,
et al. The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis. International Journal of Molecular Sciences. 2022; 23(17):10150.
https://doi.org/10.3390/ijms231710150
Chicago/Turabian Style
Colasanti, Tania, Katia Stefanantoni, Cristina Fantini, Clarissa Corinaldesi, Massimiliano Vasile, Francesco Marampon, Luigi Di Luigi, Cristina Antinozzi, Paolo Sgrò, Andrea Lenzi,
and et al. 2022. "The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis" International Journal of Molecular Sciences 23, no. 17: 10150.
https://doi.org/10.3390/ijms231710150
APA Style
Colasanti, T., Stefanantoni, K., Fantini, C., Corinaldesi, C., Vasile, M., Marampon, F., Di Luigi, L., Antinozzi, C., Sgrò, P., Lenzi, A., Riccieri, V., & Crescioli, C.
(2022). The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis. International Journal of Molecular Sciences, 23(17), 10150.
https://doi.org/10.3390/ijms231710150
